{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:04:04Z","timestamp":1788537844567,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejca.2026.116590","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:06:36Z","timestamp":1771315596000},"page":"116590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9912-9651","authenticated-orcid":false,"given":"Eva","family":"Kalfala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Meurgey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7893-3116","authenticated-orcid":false,"given":"Cl\u00e9mence","family":"H\u00e9non","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9904-166X","authenticated-orcid":false,"given":"Mehdi","family":"Brahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-9274","authenticated-orcid":false,"given":"Maud","family":"Toulmonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Boudou-Rouquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4414-7760","authenticated-orcid":false,"given":"Emmanuelle","family":"Bompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-6261","authenticated-orcid":false,"given":"Nelly","family":"Firmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2057-3557","authenticated-orcid":false,"given":"Florence","family":"Duffaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Desmoulins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Ducoulombier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1162-214X","authenticated-orcid":false,"given":"Mathilde","family":"Cancel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4534-8783","authenticated-orcid":false,"given":"Sarah","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3345-4901","authenticated-orcid":false,"given":"Mohamed","family":"Khettab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1074-8990","authenticated-orcid":false,"given":"Tiffany","family":"Darbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Guillemet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-4903","authenticated-orcid":false,"given":"Justine","family":"Gantzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6493-4999","authenticated-orcid":false,"given":"Anne-Laure","family":"Genevois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-139X","authenticated-orcid":false,"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-6867","authenticated-orcid":false,"given":"Sylvie","family":"Chabaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-120X","authenticated-orcid":false,"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-3526","authenticated-orcid":false,"given":"Armelle","family":"Dufresne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejca.2026.116590_bib1","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1002\/cncr.33618","article-title":"Bov\u00e9e JVMG, et al. Ultra-rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities","volume":"127","author":"Stacchiotti","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2026.116590_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(20010201)91:3<585::AID-CNCR1038>3.0.CO;2-0","article-title":"Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution","volume":"91","author":"Portera","year":"2001","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116590_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1186\/s12885-022-09968-5","article-title":"Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study","volume":"22","author":"Fujiwara","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116590_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000071199","article-title":"Alveolar soft part sarcoma in Japan: multi-institutional study of 57 patients from the Japanese Musculoskeletal Oncology Group","volume":"65","author":"Ogose","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2026.116590_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/907179","article-title":"Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature","volume":"2012","author":"Ogura","year":"2012","journal-title":"Sarcoma"},{"issue":"11","key":"10.1016\/j.ejca.2026.116590_bib6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0959-8049(03)00264-8","article-title":"Chemotherapy in alveolar soft part sarcomas: What do we know?","volume":"39","author":"Reichardt","year":"2003","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116590_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1634\/theoncologist.2017-0161","article-title":"Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma","volume":"23","author":"Stacchiotti","year":"2018","journal-title":"Oncologist"},{"issue":"9829","key":"10.1016\/j.ejca.2026.116590_bib8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ejca.2026.116590_bib9","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.2012.47.4288","article-title":"Cediranib for Metastatic Alveolar Soft Part Sarcoma","volume":"31","author":"Kummar","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2026.116590_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(19)30215-3","article-title":"Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"20","author":"Judson","year":"2019","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2026.116590_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1158\/1078-0432.CCR-22-2145","article-title":"Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma","volume":"29","author":"Nguyen","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ejca.2026.116590_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/annonc\/mdx774","article-title":"Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 \u2018CREATE","volume":"29","author":"Sch\u00f6ffski","year":"2018","journal-title":"Ann Oncol"},{"issue":"24","key":"10.1016\/j.ejca.2026.116590_bib13","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1158\/1078-0432.CCR-20-2819","article-title":"Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study","volume":"26","author":"Shi","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.ejca.2026.116590_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2303383","article-title":"Atezolizumab for Advanced Alveolar Soft Part Sarcoma","volume":"389","author":"Chen","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejca.2026.116590_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1470-2045(19)30153-6","article-title":"Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial","volume":"20","author":"Wilky","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116590_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001561","article-title":"Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib\/II trial","volume":"8","author":"Martin-Broto","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2026.116590_bib17","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1470-2045(22)00392-8","article-title":"Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial","volume":"23","author":"Somaiah","year":"2022","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2026.116590_bib18","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1158\/1078-0432.CCR-22-0871","article-title":"Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.ejca.2026.116590_bib19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1470-2045(23)00282-6","article-title":"Pembrolizumab in patients with rare and ultra-rare sarcomas (AcS\u00e9 Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial","volume":"24","author":"Blay","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2026.116590_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114003","article-title":"How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma","volume":"202","author":"Stacchiotti","year":"2024","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2026.116590_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108483","article-title":"Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experience","volume":"50","author":"Genevois","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116590_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jso.24183","article-title":"Prognostic factors in alveolar soft part sarcoma: A SEER analysis","volume":"113","author":"Wang","year":"2016","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2026.116590_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102045","article-title":"Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry","volume":"8","author":"Hindi","year":"2023","journal-title":"ESMO Open"},{"issue":"5","key":"10.1016\/j.ejca.2026.116590_bib24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.surg.2020.06.007","article-title":"Characterization of alveolar soft part sarcoma using a large national database","volume":"168","author":"Hagerty","year":"2020","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ejca.2026.116590_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19890101)63:1<1::AID-CNCR2820630102>3.0.CO;2-E","article-title":"Alveolar soft-part sarcoma. A clinico-pathologic study of half a century","volume":"63","author":"Lieberman","year":"1989","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.116590_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2026.116590_bib27","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2020.1707","article-title":"Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial","volume":"323","author":"Tap","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ejca.2026.116590_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/cam4.1931","article-title":"Very long-term survivors among patients with metastatic soft tissue sarcoma","volume":"8","author":"Carbonnaux","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2026.116590_bib29","article-title":"Local therapies for metastatic sarcoma: why, when, and how?","volume":"43","author":"Hindi","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"11","key":"10.1016\/j.ejca.2026.116590_bib30","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2730","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116590_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.annonc.2024.01.001","article-title":"Improved nationwide survival of sarcoma patients with a network of reference centers","volume":"35","author":"Blay","year":"2024","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2026.116590_bib32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s12094-015-1308-9","article-title":"A retrospective analysis of lung metastasis in 64 patients with alveolar soft part sarcoma","volume":"17","author":"Liu","year":"2015","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116590_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26953","article-title":"Alveolar soft part sarcoma in children and young adults: A report of 69 cases","volume":"65","author":"Flores","year":"2018","journal-title":"Pedia Blood Cancer"},{"issue":"22","key":"10.1016\/j.ejca.2026.116590_bib34","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.21037\/atm-20-6377","article-title":"Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases","volume":"8","author":"Liu","year":"2020","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.116590_bib35","first-page":"375","article-title":"Alveolar soft tissue sarcoma: a report of 50 cases at a single institution","volume":"123","author":"Zhao","year":"2023","journal-title":"Acta Chir Belg"},{"issue":"7","key":"10.1016\/j.ejca.2026.116590_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1634\/theoncologist.2018-0074","article-title":"Brain metastases and place of antiangiogenic therapies in alveolar soft part sarcoma: a retrospective analysis of the French Sarcoma Group","volume":"24","author":"Malouf","year":"2019","journal-title":"Oncologist"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:38:00Z","timestamp":1774031880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"alternative-id":["S0959804926003709"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116590","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116590"}}